본문 바로가기
KERD
논문KCI 등재

Antiphospholipid Syndrome and Vascular Ischemic (Occlusive) Diseases: An Overview

1

조회

0

다운로드

2

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Antiphospholipid syndrome (APS) is primarily considered to be an autoimmune pathological condition that is also referred to as "Hughes syndrome". It is characterized by arterial and/or venous thrombosis and pregnancy pathologies in the presence of anticardiolipin antibodies and/or lupus anticoagulant. APS can occur either as a primary disease or secondary to a connective tissue disorder, most frequently systemic lupus erythematosus (SLE). Damage to the nervous system is one of the most prominent clinical constellations of sequelae in APS and includes (i) arterial/ venous thrombotic events, (ii) psychiatric features and (iii) other non- thrombotic neurological syndromes. In this overview we compare the most important vascular ischemic (occlusive) disturbances (VIOD) with neuro-psychiatric symptomatics, together with complete, updated classifications and hypotheses for the etio-pathogenesis of APS with underlying clinical and laboratory criteria for optimal diagnosis and disease management.

참고문헌 (96)

  1. Snchez- Guerrero J, "et al. Anti-phospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine", pp.353~65 (1989)
  2. Wilson WA, "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop", 42, pp.1309~1311 (1999)
  3. Lockshin MD, "Validation of the Sapporo criteria for antiphospholipid syndrome", 43, pp.440~443 (2000)
  4. Pierangeli SS, "Anticardiolipin testing. In: Khamashta MA, editor. Hughes’ syndrome", pp.205~213 (2000), London: Springer
  5. Mackie IJ, "Lupus anticoagulant measurement. In: Khamashta MA, editor. Hughes’ syndrome", pp.214~224 (2000), London: Springer
  6. Brandt JT, "Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant", Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH, 1995, pp.74, 1185~1190
  7. Roubey RAS, "Antiphospholipid antibody-negative syndrome-other phospholipids. In: Khamashta MA, editor. Hughes’ syndrome", pp.253~260 (2000), London: Springer
  8. Lee RM, "Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome", 181, pp.642~648 (1999)
  9. Rand JH, "Molecular pathogenesis of the antiphospholipid syndrome", 90, pp.29~37 (2002)
  10. Giannakopoulos B, "Current concepts on the pathogenesis of the antiphospholipid syndrome", 109, pp.422~430 (2007)
  11. Sherer Y, "Pathogenesis of the antiphospholipid syndrome", 2, pp.492~496 (2004)
  12. Shoenfeld Y, "Infectious origin of the antiphospholipid syndrome", 65, pp.2~6 (2006)
  13. Kochenour NK, "Scott JR. A New postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987", pp.460~8
  14. Kupferminc MJ, "Severe postpartum pulmonary, cardiac and renal syndrome associated with antiphospholipid antibodies", 83, pp.806~807 (1994)
  15. Cervera R, "Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature", 76, pp.203~212 (1997)
  16. L Thi Huong D, "et al. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome. J Rheumatol 1993", pp.1229~32
  17. Hochfeld M, "Pregnancy complicated by primary antiphospholipid antibody syndrome", 83, pp.804~805 (1994)
  18. Ornstein MH, "An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases", 21, pp.1360~1364 (1994)
  19. Cervera R, "Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients", 46, pp.1019~1027 (2002)
  20. Asherson RA, "Milestones in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid syndrome Autoimmune thrombosis.", pp.3~9 (2002), Amsterdam: Elsevier
  21. Bruce D, "Left ventricular thrombi in a patient with the antiphospholipid syndrome", 74, pp.202~203 (1995)
  22. O'Neill D, "Dissolution of intracardiac mass lesions in the primary antiphospholipid antibody syndrome", 155, pp.325~327 (1995)
  23. Nickele GA, "Primary antiphospholipid syndrome and mitral valve thrombosis", 128, pp.1245~1247 (1994)
  24. Murphy JJ, "Leach IH. Findings of necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989", pp.61~4
  25. Leung WH, "Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990", pp.411~9
  26. Hasnie AM, "Diastolic dysfunction is a feature of the antiphospholipid syndrome", 129, pp.1009~1013 (1995)
  27. Martinez-Levin M, "ntiphospholipid syndrome in patients with cyanotic congenital heart disease", 13, pp.489~491 (1995)
  28. Donaldson MC, "Mannick JA. Screening for hypercoagulable states in vascular surgical practice", pp.825~31
  29. Shortell CK, "DeWeese JA. Vascular disease in the antiphospholipid syndrome a comparison with the patient population with atherosclerosis. J Vasc Surg 1992", pp.158~66
  30. Taylor LM, "Porter JM. Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study. Ann Surg 1994", pp.545~51
  31. Liote F, "Osteoarticular manifestations in the antiphospholipid syndrome. In: Asherson R A, Cervera R, Piette J-C, Shoenfeld Y, editors. The Antiphospholipid Syndrome", pp.195~200 (1996), Boca Raton: CRC Press
  32. Asherson RA, "et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993", pp.284~8
  33. Nagasawa K, "et al. Avascular necrosis of bone in systemic lupus erythematosus possible role of haemostatic abnormalities. Ann Rheum Dis 1989", pp.672~6
  34. Kleiner RC, "Kaplan HJ. Vaso-occlusive retinopathy associated with antiphospholipid antibodies", pp.896~904
  35. Phillips SA, "Zwi S. Severe immune thrombocytopenia and the development of skin infarctions in a patient with an overlap syndrome. J Rheumatol 1989", pp.1494~6
  36. Aronoff DM, "Necrosing livedo reticularis in a patient with recurrent pulmonary hemorrhage", 37, pp.300~302 (1997)
  37. Del Castillo LF, "Widespread cutaneous necrosis and antiphospholipid antibodies: Two episodes related to surgical manipulation and urinary tract infection", 36, pp.872~875 (1997)
  38. Amster MS, "Pincus S. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1993", pp.853~7
  39. Wolf P, "Kerl H. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies. Arch Dermatol 1991", pp.1739~40
  40. Hill VA, "Smith NP. Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides. Br J Dermatol 1994", pp.92~6
  41. Liano F, "Teruel JL. Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulation factor. Nephrol Dial Transplant 1988", pp.684~9
  42. Grob JJ, "Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature. J Am Acad Dermatol 1986", pp.211~9
  43. Asherson RA, "Hughes GR. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome--a report of two cases. Clin Exp Dermatol 1992", pp.266~9
  44. Asherson RA. Subungual splinter haemorrhages, "a new sign of the antiphospholipid coagulopathy", pp.268~
  45. Branch DW, "Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989", pp.228~32
  46. Fawcett RS, "Nail abnormalities: clues to systemic disease", 69, pp.1417~1424 (2004)
  47. Ruffatti A, "Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus", 14, pp.402~404 (1995)
  48. Prez-Vzquez ME, "Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome with systemic lupus erythematosus. Semin Arthritis Rheum 1992", pp.275~86, Villa AR
  49. Atanassova PA, "Neurological and systemic disorders in antiphospholipid syndrome: novel constellations on a genetic basis", 108, pp.814~ (2006)
  50. Luchi ME, "Lahita RG. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 1992", pp.700~5
  51. Brucato A, "et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J Rheumatol 1994", pp.942~4
  52. Weiss L, "Angelova M. The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis. Proc Natl Acad Sci U S A 1985", pp.5737~41
  53. Kerr JE, "Antiphospholipid antibody syndrome presenting as a refractory non-inflammatory pulmonary vasculopathy", 112, pp.1707~1710 (1997)
  54. Crausman RS, "Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome", 22, pp.554~556 (1995)
  55. Asherson RA, "Recurrent alveolar haemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome", 7, pp.30~33 (2001)
  56. Savin H, "et al. Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatol 1994", pp.977~80
  57. Piette J-C, "Renal manifestations in the antiphospholipid syndrome. In: The Antiphospholipid Syndrome. Asherson RA, Cervera R, Piette J-C, Shoenfeld Y (editrs)", pp.169~181 (1996), New York: CRC Press. Boca Raton
  58. Frampton G, "Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991", pp.1225~31
  59. Glueck HI, "Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985", pp.1389~95
  60. Sobel BJ, "Migdal SD. Noninflammatory renal microangiopathy of systemic lupus erythematosus", pp.144~59
  61. Goldstein MH, "Renal Pathology with Clinical and Functional Correlates. Tister CC", pp.19891081~113, Bernstein J. Thrombotic angiopathy including haemolytic-uremic syndrome J B Lippincott
  62. Hughson MD, "Silva T. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992", pp.150~8
  63. Oelkers W, "Adrenal insufficiency", 335, pp.1206~1212 (1996)
  64. Blanc PL, "Acute adrenal insufficiency during unilateral adrenal hemorrhage secondary to the antiphospholipid syndrome", 27, pp.970~972 (2006)
  65. Valla D, "Benhamou JP. Disorders of the hepatic veins and venules. In Oxford Textbook of Clinical Hepatology", pp.19911004~11, Rodes J. Oxford University Press
  66. Koster JC, "et al. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies need for prolonged anticoagulant treatment. Gut 1994", pp.1004~6
  67. Van Maercke YM, "et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991" (1919)
  68. Takahaski C, "Portal hypertension associated with anticardiolipin antibodies in a case of systemic lupus erythematosus", 4, pp.232~235 (1995)
  69. Mantz FA, "Craige E. Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. AMA Arch Pathol 1951", pp.91~7
  70. Nakamura H, "et al. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody. Hepatogastroenterology 1989", pp.393~7
  71. Oh H, "et al. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991", pp.147~9
  72. Perez Ruiz F, "Moreno-Caparros A. Nodular regenerative hyperplasia of the liver in rheumatic diseases report of seven cases and review of the literature. Semin Arthritis Rheum 1991", pp.47~54
  73. Morl RM, "Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature", 8, pp.160~163 (1999)
  74. Kesler A, "Cerebral venous thrombosis and chronic active hepatitis as part of the antiphospholipid antibody syndrome", 72, pp.690~692 (1996)
  75. Dourakis SP, "Autoimmune hepatitis associated with the antiphospholipid syndrome", 13, pp.591~593 (2001)
  76. Prieto J, "Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome", 23, pp.199~204 (1996)
  77. Muoz-Rodrguez FJ, "Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome", 30, pp.770~773 (1999)
  78. Alric L, "Association of antiphospholipid syndrome and chronic hepatitis C", 37, pp.589~590 (1998)
  79. Chedid A, "et al. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994", pp.1465~71
  80. Violi F, "et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ 1994", pp.239~40
  81. Atanassova PA, "Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report", 55, pp.42~43 (2006)
  82. "Cappell MS. Eesophageal necrosis and perforation associated with the anticardiolipin antibody syndrome. Am J Gastroenterol 1994", pp.1241~5
  83. Kalman DR, "Giant gastric ulceration associated with antiphospholipid antibody syndrome", 91, pp.1244~1247 (1996)
  84. Reyes E, "Alarcn-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992", pp.623~5
  85. Vahl AC, "Superior mesenteric artery occlusion andperipheral emboli caused by an aortic ulcer in a young patient with antiphospholipid syndrome", 121, pp.588~590 (1997)
  86. Mikhail N, "Gujral N. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci 1994", pp.1359~64
  87. Gl A, "Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease", 15, pp.207~210 (1996)
  88. North JP, "Wollenman OJ. Venous mesenteric occlusion in the course of migratory thrombophlebitis. Surg Gynecol Obstet 1952", pp.665~7
  89. Souto JC, "Antiphospholipid antibodies in inflammatory bowel disease", 40, pp.1524~1525 (1995)
  90. Chang KY, "et al. Anti-cardiolipin antibody associated with acute hemorrhagic pancreatitis. Pancreas 1993", pp.654~7
  91. Date K, "Antiphospholipid antibody syndrome presenting as acute acalculous cholecystitis", 92, pp.2127~2128 (1997)
  92. Arnold MH, "Schrieber L. Splenic and renal infarction in systemic lupus erythematosus association with anti- cardiolipin antibodies. Clin Rheumatol 1988", pp.406~10
  93. Pettersson T, "Julkunen H. Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies. J Rheumatol 1992", pp.1159~
  94. Gomez-Puerta JA, "Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients", 35, pp.322~332 (2006)
  95. Ruiz-Irastorza G, "Hughes syndrome crosses boundaries", 1, pp.43~48 (2002)
  96. Bird AG, "Disseminated intravascular coagulation, antiphospholipid"

관련 논문AI추천

이 간행물의 다른 논문 (12건)